NIH-funded research R21 grant

Gaussian outcomes with informed sampling for long-term studies of alcohol and depressive symptoms in HIV care

Official title: Gaussian outcomes Using Informed sampling strategies for Longitudinal studies with non-ignorable Dropout (GUILD) applied to the LATITUIDE (ACTG A5359) PEth substudy

Funded at University of Colorado Denver · NIH-11470085 · Data updated 2026-11-12

A new project will test a smarter way to study how baseline alcohol use affects changes in depressive symptoms over time in people with HIV, using smarter sampling to save cost and protect precious data.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver
NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project startSeptember 15, 2026
Project endAugust 31, 2028
Funding year2026
Award (this year)$192,032
NIH project number1R21AA033596-01
Project IDNIH-11470085 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with HIV enrolled in longitudinal studies who have varying levels of baseline alcohol exposure and would be followed for depressive symptoms.

Less likely to help

Participants in studies without longitudinal follow-up or without depressive symptom outcomes may not directly benefit.

What this research studies

This work adapts advanced statistical methods to analyze long-term study data without needing to test every sample. It focuses on continuous outcomes like depressive symptoms and uses informed sampling strategies when some participants drop out. The team will develop new analysis and study-design tools, validate them with simulations based on an HIV-related cohort, and share an R package with tutorials for broad use. The goal is to make future studies more efficient and accurate when specimens are limited or costly to assay. The LATITUDE HIV study and its LA(P)D sub-study provide the real-world context for applying these methods.

Why it matters

Potential benefit: If successful, the methods could enable more reliable conclusions from long-term HIV studies while reducing cost and preserving precious biospecimens.

How similar studies have gone: Previous work with binary outcomes showed valid inference under informative dropout; this project extends to Gaussian/continuous outcomes.

Where this research is happening

  • University of Colorado Denver
    Aurora, United States
    Active

Researchers

  • Principal investigator: Mawhinney-Delson, Samantha — University of Colorado Denver
  • Study coordinator: Mawhinney-Delson, Samantha

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.